The timing of onset for secondary malignancies did not show a clear trend, with six cases reported within 2 years of lung cancer treatment initiation and six cases reported after 2 years.
← all excerpts
Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy.
1
—
—